Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gadolinium texaphyrin

(GA-doh-LIH-nee-um tek-SA-fih-rin)
A substance being studied in the treatment and diagnosis of some types of cancer. It builds up in some cancer cells, which may make them easier to kill with radiation therapy and chemotherapy. Gadolinium texaphyrin is also used in magnetic resonance imaging (MRI) to help find cancer cells in the body. It is a type of radiosensitizing agent, a type of chemosensitizing agent, and a type of contrast agent. Also called motexafin gadolinium.
Search NCI's Dictionary of Cancer Terms